Avtor/Urednik		Lizrova Preiningerova, Jana; Baumhackl, Ulf; Csepany, Tunde; Czaplinski, Adam; Deisenhammer, Florian; Derfuss, Tobias; Hojs-Fabjan, Tanja; Fazekas, Franz; Fuchs, Siegrid; Havrdova, Eva; Horvat-Ledinek, Alenka; Illes, Zsolt; Šega, Saša; Klimova, Eleonora; Komoly, Samuel; Kurča, Egon; Linnebank, Michael; Lisy, Lubomir; Mares, Jan; Prochazkova, Lubica; Csilla, Rozsa; Szilasiova, Jarmila; Stourac, Pavel; Talab, Radomir; Turčáni, Peter; Vachova, Marta; Vecsei, Laszlo; Vodušek, David B.; Zapletalova, Olga; Berger, Thomas
Naslov		Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)
Tip		članek
Vol. in št.		Letnik 19, št. 5
Leto izdaje		2013
Obseg		str. 302-306
ISSN		1755-5930 - CNS neuroscience & therapeutics
Jezik		eng
Abstrakt		Prolonged-release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary of data on fampridine PR and recommendations on practical use of the medication in clinical practice, prediction, and evaluation of response to treatment and patient management.
Proste vsebinske oznake		multipla skleroza zdravljenje z zdravili centralni živčni sistem hoja, hitrost aminopiridin fampridin učinki zdravljenja